SETD2 is a H3K36 tri-methyltransferase and tumor suppressor that is frequently mutated in pediatric high grade glioma. SETD2 loss may be linked to transcription defects that promote gliomagenesis.
Get the Latest
news, articles, and resources sent to your inbox.